Benjamin J. Wilkins, Ph.D. - Publications

Affiliations: 
2004 University of Cincinnati, Cincinnati, OH 
Area:
Molecular Biology

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Zhao X, Lorent K, Wilkins B, Marchione DM, Gillespie K, Waisbourd-Zinman O, So J, Koo KA, Shin D, Porter JR, Wells RG, Blair I, Pack M. Glutathione antioxidant pathway activity and reserve determine toxicity and specificity of the biliary toxin biliatresone in zebrafish. Hepatology (Baltimore, Md.). PMID 27102575 DOI: 10.1002/Hep.28603  0.48
2015 Shen TC, Albenberg L, Bittinger K, Chehoud C, Chen YY, Judge CA, Chau L, Ni J, Sheng M, Lin A, Wilkins BJ, Buza EL, Lewis JD, Daikhin Y, Nissim I, et al. Engineering the gut microbiota to treat hyperammonemia. The Journal of Clinical Investigation. 125: 2841-50. PMID 26098218 DOI: 10.1172/Jci79214  0.48
2014 Mistovich RJ, O'Toole PO, Chauvin NA, Wilkins BJ, Ganley TJ. Left knee pain and bilateral knee swelling in an adolescent. Clinical Orthopaedics and Related Research. 472: 3591-8. PMID 25163688 DOI: 10.1007/s11999-014-3883-4  0.48
2014 Wilkins BJ, Gong W, Pack M. A novel keratin18 promoter that drives reporter gene expression in the intrahepatic and extrahepatic biliary system allows isolation of cell-type specific transcripts from zebrafish liver. Gene Expression Patterns : Gep. 14: 62-8. PMID 24394404 DOI: 10.1016/j.gep.2013.12.002  0.48
2013 Wilkins BJ, Lorent K, Matthews RP, Pack M. p53-mediated biliary defects caused by knockdown of cirh1a, the zebrafish homolog of the gene responsible for North American Indian Childhood Cirrhosis. Plos One. 8: e77670. PMID 24147052 DOI: 10.1371/journal.pone.0077670  0.48
2013 Wilkins BJ, Pack M. Zebrafish models of human liver development and disease. Comprehensive Physiology. 3: 1213-30. PMID 23897685 DOI: 10.1002/cphy.c120021  0.48
2007 Purcell NH, Wilkins BJ, York A, Saba-El-Leil MK, Meloche S, Robbins J, Molkentin JD. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proceedings of the National Academy of Sciences of the United States of America. 104: 14074-9. PMID 17709754 DOI: 10.1073/Pnas.0610906104  0.48
2006 Liu Q, Wilkins BJ, Lee YJ, Ichijo H, Molkentin JD. Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth. Molecular and Cellular Biology. 26: 3785-97. PMID 16648474 DOI: 10.1128/Mcb.26.10.3785-3797.2006  0.48
2005 Sanna B, Bueno OF, Dai YS, Wilkins BJ, Molkentin JD. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth. Molecular and Cellular Biology. 25: 865-78. PMID 15657416 DOI: 10.1128/Mcb.25.3.865-878.2005  0.48
2004 Wilkins BJ, Molkentin JD. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochemical and Biophysical Research Communications. 322: 1178-91. PMID 15336966 DOI: 10.1016/J.Bbrc.2004.07.121  0.48
2004 Lips DJ, Bueno OF, Wilkins BJ, Purcell NH, Kaiser RA, Lorenz JN, Voisin L, Saba-El-Leil MK, Meloche S, Pouysségur J, Pagès G, De Windt LJ, Doevendans PA, Molkentin JD. MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation. 109: 1938-41. PMID 15096454 DOI: 10.1161/01.Cir.0000127126.73759.23  0.48
2004 Parsons SA, Millay DP, Wilkins BJ, Bueno OF, Tsika GL, Neilson JR, Liberatore CM, Yutzey KE, Crabtree GR, Tsika RW, Molkentin JD. Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy. The Journal of Biological Chemistry. 279: 26192-200. PMID 15082723 DOI: 10.1074/Jbc.M313800200  0.48
2004 Searle JS, Schollaert KL, Wilkins BJ, Sanchez Y. The DNA damage checkpoint and PKA pathways converge on APC substrates and Cdc20 to regulate mitotic progression. Nature Cell Biology. 6: 138-45. PMID 14743219 DOI: 10.1038/Ncb1092  0.48
2004 Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, Jones F, Kimball TR, Molkentin JD. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circulation Research. 94: 110-8. PMID 14656927 DOI: 10.1161/01.Res.0000109415.17511.18  0.48
2004 Bueno OF, Lips DJ, Kaiser RA, Wilkins BJ, Dai YS, Glascock BJ, Klevitsky R, Hewett TE, Kimball TR, Aronow BJ, Doevendans PA, Molkentin JD. Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction. Circulation Research. 94: 91-9. PMID 14615291 DOI: 10.1161/01.Res.0000107197.99679.77  0.48
2003 Liang Q, Bueno OF, Wilkins BJ, Kuan CY, Xia Y, Molkentin JD. c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling. The Embo Journal. 22: 5079-89. PMID 14517246 DOI: 10.1093/Emboj/Cdg474  0.48
2003 Parsons SA, Wilkins BJ, Bueno OF, Molkentin JD. Altered skeletal muscle phenotypes in calcineurin Aalpha and Abeta gene-targeted mice. Molecular and Cellular Biology. 23: 4331-43. PMID 12773574 DOI: 10.1128/Mcb.23.12.4331-4343.2003  0.48
2003 Braz JC, Bueno OF, Liang Q, Wilkins BJ, Dai YS, Parsons S, Braunwart J, Glascock BJ, Klevitsky R, Kimball TF, Hewett TE, Molkentin JD. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. The Journal of Clinical Investigation. 111: 1475-86. PMID 12750397 DOI: 10.1172/Jci17295  0.48
2002 Wilkins BJ, De Windt LJ, Bueno OF, Braz JC, Glascock BJ, Kimball TF, Molkentin JD. Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth. Molecular and Cellular Biology. 22: 7603-13. PMID 12370307 DOI: 10.1128/Mcb.22.21.7603-7613.2002  0.48
2002 Wilkins BJ, Molkentin JD. Calcineurin and cardiac hypertrophy: where have we been? Where are we going? The Journal of Physiology. 541: 1-8. PMID 12015416 DOI: 10.1113/Jphysiol.2002.017129  0.48
2002 Bueno OF, Wilkins BJ, Tymitz KM, Glascock BJ, Kimball TF, Lorenz JN, Molkentin JD. Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 99: 4586-91. PMID 11904392 DOI: 10.1073/Pnas.072647999  0.48
Show low-probability matches.